The structures ofeurystatins A and B, new prolyl endopeptidase inhibitors, have been elucidated by chemical degradation and spectral studies. They have in commona unique 13-memberedcyclic peptide core composedof L-leucine, L-ornithine and (S)-3-amino-2-oxobutyric acid, and differ from each other in the a,/?-unsaturated fatty acid attached to the a-amino moiety of the ornithine.
In the preceding paper1*, we described the fermentation, isolation, and specific prolyl endopeptidase inhibitory activities of eurystatins A and B produced by Streptomyces eurythermus. This paper describes the physico-chemical properties and structural studies on eurystatins A and B.
Physico-chemical Properties and Spectral Analyses Eurystatins A (la) and B (lb) were obtained as colorless fine needles from aqueous acetonitrile. They indicating that lb was a CH2unit larger than la. The IR spectra of both compounds ( Fig. 2 (la) ) are similar exhibiting typical peptide absorption bands at around 1650 and 1530cm"1 and their LHNMR spectra are also very similar ( Fig. 3 (la) ). The 13C NMRof la was not analyzed well due to its poor solubility in the NMRsolvents, but the spectrum of lb showed clear 24 carbon signals ( (Fig. 4) . Although the 2D NMRexperiments were not available for la, its *H NMRindicated a 6-methyl-2-heptenoyl group (partial structure A' in Fig. 4 ) instead of partial structure A of lb, reflecting the molecular difference between la and lb.
Degradation Study
Upon hydrolysis with 6n HC1 at 110-120°C, la yielded, after chromatography on Dowex 50 WX8, L-leucine and L-ornithine whose configuration was determined by HPLC using a chiral Acid hydrolysis of lb afforded a new fatty acid (FA2) together with L-leucine and L-ornithine. The IR, rH NMRand CI-MS (m/z 1 57 (M + H) +) of FA2 indicated (£)-6-methyl-2-octenoic acid, substantiating the partial structures A' (of la) and A (of lb) assigned by the NMRexperiments. Thus, the difference between la and lb was shown to be only in the fatty acid moiety. NaBH4reduction of la gave a dihydro derivative 2a which showed two peaks in the HPLC.They were separated by preparative HPLCto 2a1 and 2a2 which showed the same molecular ion peak at m/z 452 in the EI-MS spectra. In *H NMRspectrum of2a1? a new doublet methine proton (S 3.92, d, /= 1.7 Hz) bearing a hydroxy group was observed indicating that the ketone in la was reduced to a secondary alcohol giving two diastereoisomers 2aj and 2a2. Acid hydrolysis of the 2a mixture gave L-leucine, L-ornithine and a new compound 3. The molecular formula of 3 was determined to be C4H9NO3by its HRFAB-MS (m/z 120.0657 (M+H)+). Compound 3 was determined to be a diastereoisomeric mixture of 3-amino-2-hydroxybutyric acid2) by *H NMRspectrum. Upon oxidation with Fenton reagent3'40, 3 gave alanine, whose configuration was determined to be l by chiral HPLC.Thus the original amino acid in eurystatin (partial structures D and E) was determined to be (S)-3-amino-2-oxobutyric acid.
Sequence of the Structural Compounds In order to increase solubility in NMRsolvents, 2a was acetylated to yield the monoacetate (4a). Upon silica gel chromatography and subsequent preparative HPLC,4a was separated to 4ax and 4a2, both of which showed the molecular ions at m/z 495 (M+H)+. Extensive 2D-NMRexperiments were carried out for 4a1? which exhibited higher solubility than 4a2. It showed a new low-field methine signal at (5 5.01 (d, /=2.1 Hz) due to acetylation in the *H NMR,and the presence of six methyl, six methylene, six methine, two olefin, and five carbonyl carbons in the 13C NMR.The 13C-1H long range COSY experiment combined with 1H-1H and 13C-XH2D NMRallowed to assign all proton and carbon signals of 4a1 and also to sequence the structural units, L-leucine, L-ornithine, (»S)-3-amino-2-oxobutyric acid and 6-methyl-2-heptenoic acid establishing a unique 1 3-memberedcyclic peptide structure substituted with the acyl side chain (Fig. 5) . The structures of la and lb were determined as shown in Fig. 1 .
Discussion
The structures of eurystatins A and B have been determined based on the spectroscopic analysis and partial degradation experiments. They have in commona unique 13-memberedcyclic peptide core and OCT. 1992 differ from each other in the acyl side chain. As reported in the preceding paperX), they showed specific and strong prolyl endopeptidase inhibitory activities. It is particularly interesting that reduction of the keto carbonyl of eurystatin completely lost the enzyme inhibitory activity. This indicated that the a-keto group of 3-amino-2-oxobutyric acid is very essential for the activity of the antibiotics.
Recently, a new prolyl endopeptidase inhibitor poststatin was reported by the Institute of Microbial Chemistry5). It is a straight chain peptide containing a (S)-3-amino-2-oxovaleric acid (postine) which is the homolog of (S)-3-amino-2-oxobutyric acid contained in eurystatin. The ketone moiety of postine has also been identified as the key functional group for the enzyme inhibitory activity. It should be noted that cyclotheonamide, a strong thrombin inhibitor recently isolated from a marine sponge, also has a /?-amino-a-oxocarboxylic acid6). These a-keto-/?-amino acids seem to be the active center in the various peptidic enzyme inhibitors.
Experimental TLC was performed on silica gel plates (Kiesel gel 60F254, Merck). MP's were determined on a Shibayama micro melting point apparatus and were not corrected. The IR and UVspectra were determined on a Jasco IR-810 IR spectrophotometer and a Jasco UVIDEC-610Cspectrometer, respectively. The XH and 13C NMRspectra were recorded on a Jeol JNM-GX400 or Varian FT 80A spectrometer. The EI-MS, FAB-MSand CI-MSspectra were measured on a Jeol JMS-AX505H mass spectrometer. Amino acid analysis was carried out using the Waters PICO-TAGsystem.
Acid Hydrolysis of Eurystatin A (la)
A suspension of la (100mg) in a mixture of 6n HC1 (10ml) and 1,4-dioxane (4ml) was heated at 1 10°C for 18 hours in a sealed tube. The reaction mixture was extracted with ether (20ml x 4). The aqueous layer was concentrated in vacuo to give an oil, which was chromatographed on a column of Dowex50WX8 The ethereal layer was re-extracted with 0. 1 n NaOHand the aqueous extract was washed with ether. The aqueous layer was acidified with dilHC1 to pH 2 and extracted with ether. The extract was washed with water, dried over MgSO4and evaporated to give 28 mg of an oil. It was purified by preparative TLC 
NaBH4Reduction of Eurystatin A (la)
To a stirred solution of la (70mg) in 40ml of 50% aqueous EtOH was added 30mg ofNaBH4, and the stirring was continued for 3 hours at room temperature. The mixture was neutralized with dilHC1 and evaporated to remove organic solvent. The residue was extracted with BuOHand the extract was concentrated to give 71 mg of the reduction product (2a 
Oxidation of 3
To a solution of3 (3mg) in 3% H2O2 (0.12ml) was added a solution of FeSO4 (0.6mg) in 3/il of water. The mixture was heated at 50°C for 45 minutes. After dilution with water (1 ml), the mixture was passed through a column of Dowex50WX8(5mmi.d. x 30mm). The column was washed with water and eluted with 1 n NH4OH, and the eluate was monitored by ninhydrin. The ninhydrin positive fractions were combined and evaporated to dryness to afford L-alanine (1.1 mg), which was identified by TLC; Rf 0.25 (BuOH-AcOH-H2O, 3 : 1 : 1) and 0.40 (pyridine-H2O, 4: 1), amino acid analysis and HPLC using the chiral column as used for L-leucine and L-ornithine (mobile phase: 0.1him CuSO4, flow rate: 0.5ml/minute, detection: UV 254nm, temperature: 25°C, D-alanine 6.18 minutes and L-alanine 9.92 minutes).
Acetylation of 2a
A solution of2a (2a! and 2a2 mixture, 146mg) in a mixture of 3ml of acetic anhydride and 10ml of dry pyridine was stirred at room temperature for 2 days. The reaction mixture was diluted with EtOAc. After removing insoluble material by filtration, the filtrate was washed with water and dilHCl. The organic layer was evaporated in vacuo to give a solid which showed two peaks (4^l and 4a2) by HPLC (HPLCcondition same as that of 2a. Rt 4a1? 15.0 minutes and 4a2, ll.9 minutes). The solid was 494.3104).
